171 related articles for article (PubMed ID: 37398114)
21. 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner.
Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L
Neoplasia; 2012 Aug; 14(8):719-31. PubMed ID: 22952425
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
23. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
24. FOXK2 Transcription Factor and Its Emerging Roles in Cancer.
Nestal de Moraes G; Carneiro LDT; Maia RC; Lam EW; Sharrocks AD
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30897782
[TBL] [Abstract][Full Text] [Related]
25. FoxK2 is required for cellular proliferation and survival.
van der Heide LP; Wijchers PJ; von Oerthel L; Burbach JP; Hoekman MF; Smidt MP
J Cell Physiol; 2015 May; 230(5):1013-23. PubMed ID: 25216324
[TBL] [Abstract][Full Text] [Related]
26. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
Bessette DC; Tilch E; Seidens T; Quinn MC; Wiegmans AP; Shi W; Cocciardi S; McCart-Reed A; Saunus JM; Simpson PT; Grimmond SM; Lakhani SR; Khanna KK; Waddell N; Al-Ejeh F; Chenevix-Trench G
PLoS One; 2015; 10(5):e0125232. PubMed ID: 25969993
[TBL] [Abstract][Full Text] [Related]
27. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
[TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
Zhao Z; Gao J; Huang S
Dig Dis Sci; 2022 Mar; 67(3):925-935. PubMed ID: 33738672
[TBL] [Abstract][Full Text] [Related]
29. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
30. CircUBAP2 Inhibits Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma via Targeting miR-148a-3p/FOXK2 Pathway.
Sun J; Yin A; Zhang W; Lv J; Liang Y; Li H; Li Y; Li X
Cell Transplant; 2020; 29():963689720925751. PubMed ID: 32425115
[TBL] [Abstract][Full Text] [Related]
31. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma.
Kong J; Zhang Q; Liang X; Sun W
Open Med (Wars); 2020; 15(1):702-708. PubMed ID: 33313412
[TBL] [Abstract][Full Text] [Related]
32. FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway.
Zhang Y; Wang Y; Zhao G; Tanner EJ; Adli M; Matei D
J Clin Invest; 2022 May; 132(10):. PubMed ID: 35349489
[TBL] [Abstract][Full Text] [Related]
33. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
34. FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis.
Li Y; Chen J; Wang B; Xu Z; Wu C; Ma J; Song Q; Geng Q; Yu J; Pei H; Yao Y
Drug Resist Updat; 2023 Mar; 67():100926. PubMed ID: 36682222
[TBL] [Abstract][Full Text] [Related]
35. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
Okino Y; Machida Y; Frankland-Searby S; Machida YJ
J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
[TBL] [Abstract][Full Text] [Related]
36. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
37. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
38. 3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer.
Fyffe C; Falasca M
Cancer Manag Res; 2013; 5():271-80. PubMed ID: 24039447
[TBL] [Abstract][Full Text] [Related]
39. CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner.
Xu Q; Cheng D; Li G; Liu Y; Li P; Sun W; Ma D; Ni C
Int J Biol Sci; 2021; 17(9):2294-2307. PubMed ID: 34239356
[TBL] [Abstract][Full Text] [Related]
40. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
